lung-cancer

Documents about lung-cancer

• MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer#162482ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer#373657ClinicalTrials.gov
• Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC#405145ClinicalTrials.gov
• Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities#226244ClinicalTrials.gov
• Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer#158236ClinicalTrials.gov
• Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases#283033ClinicalTrials.gov
• Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer#349972ClinicalTrials.gov
• Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy#414476ClinicalTrials.gov
• Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer#429751ClinicalTrials.gov
• Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial#444874ClinicalTrials.gov
• TF2- Small Cell Lung Cancer Radio Immunotherapy#353280ClinicalTrials.gov
• Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery#28559ClinicalTrials.gov
• A Biomarker Screening Protocol for Participants With Solid Tumors#184830ClinicalTrials.gov
• Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study#136171ClinicalTrials.gov
• AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer#141096ClinicalTrials.gov
• Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer#256895ClinicalTrials.gov
• Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy#181728ClinicalTrials.gov
• C-TIL051 in Non-Small Cell Lung Cancer#429756ClinicalTrials.gov
• Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer#123464ClinicalTrials.gov
• Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer#181768ClinicalTrials.gov
• Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study#127610ClinicalTrials.gov
• Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy#346934ClinicalTrials.gov
• Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer#290984ClinicalTrials.gov
• Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer#377334ClinicalTrials.gov
• A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer#411378ClinicalTrials.gov
• MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)#238109ClinicalTrials.gov
• Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade#152420ClinicalTrials.gov
• MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer#195332ClinicalTrials.gov
• LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG#195333ClinicalTrials.gov
• A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer#303718ClinicalTrials.gov
• Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)#146464ClinicalTrials.gov
• Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)#290969ClinicalTrials.gov
• Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer#268016ClinicalTrials.gov
• Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer#353276ClinicalTrials.gov
• Ambispective Registry of Patients Affected by Lung Cancer#426783ClinicalTrials.gov
• Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer#444876ClinicalTrials.gov
• Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer#261513ClinicalTrials.gov
• Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial#184851ClinicalTrials.gov
• Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer#152403ClinicalTrials.gov
• Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases#154653ClinicalTrials.gov
• Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)#311125ClinicalTrials.gov
• Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer#18606ClinicalTrials.gov
• Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now#146443ClinicalTrials.gov
• Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer#272369ClinicalTrials.gov
• Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer#283032ClinicalTrials.gov
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer#287547ClinicalTrials.gov
• Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer#366607ClinicalTrials.gov
• Personalized DC Vaccines in Non Small Cell Lung Cancer#405221ClinicalTrials.gov
• Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer#442081ClinicalTrials.gov
• Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer#268010ClinicalTrials.gov